Human papillomavirus life cycle: Active and latent phases

Seminars in Cancer Biology

Volumn 9, Issue 6, 1999, Pages 379-386

  Stubenrauch, Frank ^a   Laimins, Laimonis A ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Differentiation; Epithelia; Human papillomavirus; Latency; Productive infection

Indexed keywords

CALCIUM BINDING PROTEIN; CAPSID PROTEIN; CELL PROTEIN; CYCLIN A; CYCLIN E; HELICASE; HEPARIN; INTEGRIN; PAXILLIN; POLYSACCHARIDE; PROTEIN P105; PROTEIN P21; PROTEIN P27; PROTEIN P53; TELOMERASE; TRANSCRIPTION FACTOR; VIRUS DNA; VIRUS PROTEIN;

CELL DIFFERENTIATION; EPITHELIUM; GENE EXPRESSION; GENE REPLICATION; HUMAN; LARYNX PAPILLOMATOSIS; LATENT PERIOD; LIFE CYCLE; NONHUMAN; ONCOVIRINAE; REVIEW; VIRION; VIRUS EXPRESSION; VIRUS INFECTION; WART VIRUS;

EID: 0033511021     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1999.0141     Document Type: Article

References (97)

1. Roizman B, Sears AE. Herpes simplex viruses and their replication, Fields BN, Knipe DM, Howley PM,. Fundamental Virology. 1996;2231-2296 Lippincott-Raven Publishers, Philadelphia.
2. Ferenczy A, Mitao M, Nagai N, Silverstein SJ, Crum CP. Latent papillomavirus and recurring genital warts. N Engl J Med. 313:1985;784-788.
3. Steinberg BM, Topp WC, Schneider PS, Abramson AL. Laryngeal papillomavirus infection during clinical remission. N Engl J Med. 308:1983;1261-1264.
4. Berg JW, Lampe JG. High-risk factors in gynecologic cancer. Cancer. 48:1981;429-441.
5. Blohme I, Brynger H. Malignant disease in renal transplant patients. Transplantation. 39:1985;23-25.
6. de Villiers EM, Lavergne D, McLaren K, Benton EC. Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer. 73:1997;356-361.
7. Penn I. Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer. 58:1986;611-616.
8. Proby C, Storey A, McGregor J, Leigh I. Does human papillomavirus infection play a role in non-melanoma skin cancer? Papillomavirus. 1996;53-60.
9. Sillman F, Stanek A, Sedlis A, Rosenthal J, Lanks KW, Buchhagen D, Nicastri A, Boyce J. The relationship between human papillomavirus and lower genital intraepithelial neoplasia in immunosuppressed women. Am J Obstet Gynecol. 150:1984;300-308.
10. Chan SY, Delius H, Halpern AL, Bernard HU. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol. 69:1995;3074-3083.
11. de Villiers EM. Papillomavirus and HPV typing. Clin Dermatol. 15:1997;199-206.
12. Favre M, Orth G, Croissant O, Yaniv M. Human papillomavirus DNA: physical map. Proc Natl Acad Sci USA. 72:1975;4810-4814.
13. Gissmann L, Pfister H, Zur Hausen H. Human papilloma viruses (HPV): characterization of four different isolates. Virology. 76:1977;569-580.
14. Heilman CA, Law MF, Israel MA, Howley PM. Cloning of human papilloma virus genomic DNAs and analysis of homologous polynucleotide sequences. J Virol. 36:1980;395-407.
15. Oltersdorf T, Campo MS, Favre M, Dartmann K, Gissmann L. Molecular cloning and characterization of human papillomavirus type 7 DNA. Virology. 149:1986;247-250.
16. Orth G, Favre M, Croissant O. Characterization of a new type of human papillomavirus that causes skin warts. J Virol. 24:1977;108-120.
17. Orth G, Jablonska S, Favre M, Croissant O, Obalek S, Jarzabek-Chorzelska M, Jibard N. Identification of papillomaviruses in butchers' warts. J Invest Dermatol. 76:1981;97-102.
18. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta. 1288:1996;55-78.
19. Dartmann K, Schwarz E, Gissmann L, zur Hausen H. The nucleotide sequence and genome organization of human papilloma virus type 11. Virology. 151:1986;124-130.
20. Gissmann L, Diehl V, Schultz-Coulon HJ, zur Hausen H. Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol. 44:1982;393-400.
21. Evander M, Frazer IH, Payne E, Qi YM, Hengst K, McMillan NA. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol. 71:1997;2449-2456.
22. Joyce JG, Tung JS, Przysiecki CT, Cook, JC, Lehman ED, Sands JA, Jansen KU, Keller PM. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem. 274:1999;5810-5822.
23. Watt FM. Epidermal stem cells: markers, patterning and the control of stem cell fate. Philos Trans R Soc London B Biol Sci. 353:1998;831-837.
24. Laimins LA. Human papillomaviruses target differentiating epithelium for virion production and malignant conversion. Semin Virol. 7:1996;305-313.
25. Halbert CL, Demers GW, Galloway DA. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J Virol. 66:1992;2125-2134.
26. Cheng S, Schmidt-Grimminger DC, Murant T, Broker TR, Chow LT. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev. 9:1995;2335-2349.
27. Ruesch MN, Laimins LA. Human papillomavirus oncoproteins alter differentiation-dependent cell cycle exit on suspension in semisolid medium. Virology. 250:1998;19-29.
28. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 248:1990;76-79.
29. Huibregtse JM, Scheffner M, Howley PM. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol Cell Biol. 13:1993;775-784.
30. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
31. Chen JJ, Reid CE, Band V, Androphy EJ. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science. 269:1995;529-531.
32. Klingelhutz AJ, Foster SA, McDougall JK. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature. 380:1996;79-82.
33. Ronco LV, Karpova AY, Vidal M, Howley PM. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12:1998;2061-2072.
34. Tong X, Howley PM. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc Natl Acad Sci USA. 94:1997;4412-4417.
35. Dyson N, Howley PM, Munger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 243:1989;934-937.
36. Dyson N, Guida P, Munger K, Harlow E. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol. 66:1992;6893-6902.
37. Chellappan S, Kraus VB, Kroger B, Munger, K, Howley PM, Phelps WC, Nevins JR. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci USA. 89:1992;4549-4553.
38. Funk JO, Waga S, Harry JB, Espling E, Stillman B, Galloway DA. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev. 11:1997;2090-2100.
39. Jones DL, Alani RM, Munger K. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev. 11:1997;2101-2111.
40. McIntyre MC, Ruesch MN, Laimins LA. Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107. Virology. 215:1996;73-82.
41. Tommasino M, Adamczewski JP, Carlotti F, Barth, CF, Manetti R, Contorni M, Cavalieri F, Hunt T, Crawford L. HPV16 E7 protein associates with the protein kinase p33CDK2 and cyclin A. Oncogene. 8:1993;195-202.
42. Zerfass-Thome K, Zwerschke W, Mannhardt B, Tindle R, Botz JW, Jansen-Durr P. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene. 13:1996;2323-2330.
43. Gage JR, Meyers C, Wettstein FO. The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties. J Virol. 64:1990;723-730.
44. Elbel M, Carl S, Spaderna S, Iftner T. A comparative analysis of the interactions of the E6 proteins from cutaneous and genital papillomaviruses with p53 and E6AP in correlation to their transforming potential. Virology. 239:1997;132-149.
45. Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol. 63:1989;4417-4421.
46. Schmitt A, Harry JB, Rapp B, Wettstein FO, Iftner T. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1. J Virol. 68:1994;7051-7059.
47. Yee AS, Shih HH, Tevosian SG. New perspectives on retinoblastoma family functions in differentiation. Front Biosci. 3:1998.
48. Androphy EJ, Lowy DR, Schiller JT. Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature. 325:1987;70-73.
49. Blitz IL, Laimins LA. The 68-kilodalton E1 protein of bovine papillomavirus is a DNA binding phosphoprotein which associates with the E2 transcriptional activator in vitro. J Virol. 65:1991;649-656.
50. Frattini MG, Laimins LA. Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein. Proc Natl Acad Sci USA. 91:1994;12398-12402.
51. Li R, Knight J, Bream G, Stenlund A, Botchan M. Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Genes Dev. 3:1989;510-526.
52. Mohr IJ, Clark R, Sun S, Androphy EJ, MacPherson P, Botchan MR. Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science. 250:1990;1694-1699.
53. Ustav M, Ustav E, Szymanski P, Stenlund A. Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. Embo J. 10:1991;4321-4329.
54. Yang L, Li R, Mohr IJ, Clark R, Botchan MR. Activation of BPV-1 replication in vitro by the transcription factor E2. Nature. 353:1991;628-632.
55. Liu JS KS, Broker TR, Chow LT. The functions of human papillomavirus type 11 E1, E2, and E2C proteins in cell-free DNA replication. J Biol Chem. 270:1995;27283-27291.
56. Lusky M, Hurwitz J, Seo YS. Cooperative assembly of the bovine papilloma virus E1 and E2 proteins on the replication origin requires an intact E2 binding site. J Biol Chem. 268:1993;15795-15803.
57. Seo YS, Muller F, Lusky M, Gibbs E, Kim HY, Phillips B, Hurwitz J. Bovine papilloma virus (BPV)-encoded E2 protein enhances binding of E1 protein to the BPV replication origin. Proc Natl Acad Sci USA. 90:1993;2865-2869.
58. Sedman J, Stenlund A. Co-operative interaction between the initiator E1 and the transcriptional activator E2 is required for replicator specific DNA replication of bovine papillomavirus in vivo and in vitro. Embo J. 14:1995;6218-6228.
59. Lusky M, Hurwitz J, Seo YS. The bovine papillomavirus E2 protein modulates the assembly of but is not stably maintained in a replication-competent multimeric E1-replication origin complex. Proc Natl Acad Sci USA. 91:1994;8895-8899.
60. Sanders CM, Stenlund A. Recruitment and loading of the E1 initiator protein: an ATP-dependent process catalysed by a transcription factor. Embo J. 17:1998;7044-7055.
61. Bream GL, Ohmstede CA, Phelps WC. Characterization of human papillomavirus type 11 E1 and E2 proteins expressed in insect cells. J Virol. 67:1993;2655-2663.
62. Hughes FJ, Romanos MA. E1 protein of human papillomavirus is a DNA helicase/ATPase. Nucleic Acids Res. 21:1993;5817-5823.
63. Seo YS MF, Lusky M, Hurwitz J. Bovine papilloma virus (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication. Proc Natl Acad Sci USA. 90:1993;702-706.
64. Yang L, Mohr I, Fouts E, Lim DA, Nohaile M, Botchan M. The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase. Proc Natl Acad Sci USA. 90:1993;5086-5090.
65. Bonne-Andrea C, Santucci S, Clertant P, Tillier F. Bovine papillomavirus E1 protein binds specifically DNA polymerase alpha but not replication protein A. J Virol. 69:1995;2341-2350.
66. Conger KL, Liu JS, Kuo SR, Chow LT, Wang TS. Human papillomavirus DNA replication. Interactions between the viral E1 protein and two subunits of human dna polymerase alpha/primase. J Biol Chem. 274:1999;2696-2705.
67. Han Y, Loo YM, Militello KT, Melendy T. Interactions of the papovavirus DNA replication initiator proteins, bovine papillomavirus type 1 E1 and simian virus 40 large T antigen, with human replication protein A. J Virol. 73:1999;4899-4907.
68. Masterson PJ, Stanley MA, Lewis AP, Romanos MA. A C-terminal helicase domain of the human papillomavirus E1 protein binds E2 and the DNA polymerase alpha-primase p68 subunit. J Virol. 72:1998;7407-7419.
69. Park P, Copeland W, Yang L, Wang T, Botchan MR, Mohr IJ. The cellular DNA polymerase alpha-primase is required for papillomavirus DNA replication and associates with the viral E1 helicase. Proc Natl Acad Sci USA. 91:1994;8700-8704.
70. Del Vecchio AM RH, Howley PM, Baker CC. Transient replication of human papillomavirus DNAs. J Virol. 66:1992;5949-5958.
71. Stubenrauch F, Lim HB, Laimins LA. Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31. J Virol. 72:1998;1071-1077.
72. Thomas JT, Hubert WG, Ruesch MN, Laimins LA. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc Natl Acad Sci USA. 96:1999;8449-8454.
73. Doorbar J PA, Hartley K, Banks L, Crook T, Stanley M, Crawford L. Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line. Virology. 178:1990;254-262.
74. Hummel M, Hudson JB, Laimins LA. Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J Virol. 66:1992;6070-6080.
75. Ozbun MA, Meyers C. Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification. Virology. 248:1998;218-230.
76. Schneider-Gadicke A, Schwarz E. Different human cervical carcinoma cell lines show similar tanscription patterns of human papillomavirus type 18 early enes. EMBO J. 5:1986;2285-2292.
77. Snijders PJ, Meijer CJ, van den Brule AJ, Schrijnemakers HF, Snow GB, Walboomers JM. Human papillomavirus (HPV) type 16 and 33 E6/E7 region transcripts in tonsillar carcinomas can originate from integrated and episomal HPV DNA. J Virol. 73:1992;2059-2066.
78. Smotkin D, Wettstein FO. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci USA. 83:1986;4680-4684.
79. Hubert WG, Kanaya T, Laimins LA. DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5′ of the minimal origin. J Virol. 73:1999;1835-1845.
80. Remm M, Remm A, Ustav M. Human papillomavirus type 18 E1 protein is translated from polycistronic mRNA by a discontinuous scanning mechanism. J Virol. 73:1999;3062-3070.
81. DiLorenzo TP, Steinberg BM. Differential regulation of human papillomavirus type 6 and 11 early promoters in cultured cells derived from laryngeal papillomas. J Virol. 69:1995;6865-6872.
82. Grassmann K, Wilczynski SP, Cook N, Rapp B, Iftner T. HPV6 variants from malignant tumors with sequence alterations in the regulatory region do not reveal differences in the activities of the oncogene promoters but do contain amino acid exchanges in the E6 and E7 proteins. Virology. 223:1996;185-197.
83. Smotkin D, Prokoph H, Wettstein FO. Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J Virol. 63:1989;1441-1447.
84. Grassmann K, Rapp B, Maschek H, Petry KU, Iftner T. Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J Virol. 70:1996;2339-2349.
85. Hummel M, Lim HB, Laimins LA. Human papillomavirus type 31b late gene expression is regulated through protein kinase C-mediated changes in RNA processing. J Virol. 69:1995;3381-3388.
86. Nasseri M, Hirochika R, Broker TR, Chow LT. A human papilloma virus type 11 transcript encoding an E1-E4 protein. Virology. 159:1987;433-439.
87. Chow LT, Reilly SS, Broker TR, Taichman LB. Identification and mapping of human papillomavirus type 1 RNA transcripts recovered from plantar warts and infected epithelial cell cultures. J Virol. 61:1987;1913-1918.
88. Terhune SS, Milcarek C, Laimins LA. Regulation of human papillomavirus type 31 polyadenylation during the differentiation-dependent life cycle. J Virol. 73:1999;7185-7192.
89. McBride AA, Romanczuk H, Howley PM. The papillomavirus E2 regulatory proteins. J Biol Chem. 266:1991;18411-18414.
90. Klumpp DJ, Laimins LA. Differentiation-induced changes in promoter usage for transcripts encoding the human papillomavirus type 31 replication protein E1. Virology. 257:1999;239-246.
91. Syrjanen KJ. Epidemiology of human papillomavirus (HPV) infections and their associations with genital squamous cell cancer. Apmis. 97:1989;957-970.
92. Nuovo GJ, Becker J, Margiotta M, MacConnell P, Comite S, Hochman H. Histological distribution of polymerase chain reaction - amplified human papillomavirus 6 and 11 DNA in penile lesions. Am J Surg Pathol. 16:1992;269-275.
93. Wettstein FO. Papillomaviruses and carcinogenic progression I: cottontail rabbit (Shope) papillomavirus, Salzman NP, Howley PM,. The Papillomaviruses. 1986.
94. Schmitt, A, Rochat A, Zeltner R, Borenstein L, Barrandon Y, Wettstein FO, Iftner T. The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells. J Virol. 70:1996;1912-1922.
95. Amella CA, Lofgren LA, Ronn AM, Nouri M, Shikowitz MJ, Steinberg BM. Latent infection induced with cottontail rabbit papillomavirus. A model for human papillomavirus latency. Am J Pathol. 144:1994;1167-1171.
96. +cells and persistence of viral DNA after regression. J Virol. 71:1997;5540-5548.
97. Maran A AC, Di Lorenzo TP, Auborn KJ, Taichman LB, Steinberg BM. Human papillomavirus type 11 transcripts are present at low abundance in latently infected respiratory tissues. Virology. 212:1995;285-294.